← Open Payments lookup

KRISTY DAY: Open Payments

NPI 1750804001 · TEXARKANA, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$433 in 23 payments from 8 companies in 2025. Trend: 2023 $465 · 2024 $422 · 2025 $433

Food & beverage: $433
CompanyPaymentsAmount
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)4$95
Takeda Pharmaceuticals U.S.A., Inc.5$82
ABBVIE INC.4$72
Novo Nordisk Inc3$55
Boehringer Ingelheim Pharmaceuticals, Inc.2$41
Astellas Pharma US Inc2$37
Lilly USA, LLC2$32
PFIZER INC.1$19

Products named: CAPLYTA, TRINTELLIX, JARDIANCE, Veozah, Wegovy, UBRELVY, QULIPTA, NURTEC ODT.

Industry payments across TX — which companies pay providers there.